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Letters to the Editorwas detected by pathologic examination. All 10 were
referred for surgical resection. None of the patients who un-
derwent endoscopic follow-up had cancer detected at the
resection site.We realize thatfibrotic and adherentflat tissue
in the base of EMR defects can be caused by cancer, but all
evidence indicates that the overwhelming majority of lesion
areas removed by avulsion in our study were simply flat or
fibrotic areas of benign polyp tissue that resisted snaring.
The point of our study was that avulsion of flat areas that
resist snaring is not associated with an increased recurrence
rate at follow-up, unlike ablation of flat areas that have re-
sisted snaring.7
Anecdotally, we have changed our electrocautery settings
(at the recommendation of the manufacturer) for avulsion
on the ERBE Vio (ERBE, Tuebingen, Germany) from the
3-1-3 (Endocut I) setting used during the study interval2 to
1-4-1 (Endocut I). This setting, combined with the use of
very brief taps on the yellow pedal after mechanical traction
is applied, leads to quick and clean separation of grasped
tissue from the defect, with very minimal thermal injury.
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https://doi.org/10.1016/j.gie.2019.07.022Endoscopic plastic stents: Still the
preferred option of treatment for
benign biliary stenosis?To the Editor:
We read with great interest the article by Costamagna
et al,1 recently published in Gastrointestinal Endoscopy,998 GASTROINTESTINAL ENDOSCOPY Volume 90, No. 6 : 2019reporting the long-term results of multiple endoscopically
placed plastic stents for the treatment of postcholecystec-
tomy biliary stricture. The article is of considerable rele-
vance because it provides robust evidence of the efficacy
of large-bore plastic stents in the treatment of benign
biliary stenosis. However, since the time of treatment of
the last patient in the series (2010), several advances
have been made in the treatment of benign biliary stenosis,
mainly aimed at reducing the invasiveness of the treat-
ment.2,3 In the series by Costamagna et al,1 patients
required a mean treatment duration of 1 year (11.8  6.4
months), during which a mean of 4.2  1.5 ERCPs per
patient was required.
Furthermore, several stents were often simultaneously
placed, with a mean maximum number of 4.3  1.6.1
Thus, with a multiple plastic stent approach, patients
need to undergo several endoscopic procedures over a
prolonged period, incurring a not inconsiderable use
of materials and costs for the healthcare system. Since
the introduction of plastic stents, several other types
of stents have been developed and applied in the
treatment of benign biliary strictures and are worthy of
mention in the discussion of this topic. In particular,
data have been published on the application of
retrievable covered self-expanding metal stents4,5 and
biodegradable stents,6-8 including multicentric experi-
ences. Both of these strategies entail the by-no-means
negligible effect of reducing the number of procedures
required to resolve the stenosis and lessen the degree
of invasiveness. Despite the lack of studies directly
comparing these strategies, reducing the number of pro-
cedures required could also lead to a reduction in overall
costs and indeed to a shorter waiting list for endoscopic
procedures.DISCLOSURE
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https://doi.org/10.1016/j.gie.2019.07.021Response:We wish to thank Dr Mauri for his letter1 because it
allows us to better explain why we are still sticking to the
multiple plastic stent (MPS) strategy in postcholecystec-
tomy biliary stricture (PCBS). We fully agree that the major
limitations of the MPS protocol are the need for repeated
ERCP and the long treatment period, as underlined in
the discussion section of our article.2
In that article, we focused on the management of PCBS,
which has peculiarities that substantially differ from those
of other benign biliary strictures, such as those occurring
after liver transplantation, in the course of chronic pancre-
atitis (CP), in the setting of primary sclerosing cholangitis,
and, maximally, after biliodigestive anastomosis. PCBSs are
usually short, occur very often at the upper third of the
common hepatic duct, and not infrequently also involve
the main hepatic confluence. These features make the
use of fully covered self-expandable metal stents (FC-
SEMSs) seldom feasible because of the risk of impaction
of the upper edge into the hilar roof, the risk of occluding
intrahepatic biliary branches, and the danger of migration
resulting from the uneven position of the released stent.
For these reasons, only 18 patients with PCBSs were
included in a large prospective multicenter study3 of 187
patients receiving FC-SEMSs for benign biliary strictures
(BBSs) of different causes, comprising also CP, and anasto-
motic strictures after liver transplantation. To our knowl-
edge, this is the largest series in the literature of FC-
SEMSs in PCBSs. The experience with self-expandable
biodegradable stents (SEBSs) in BBSs is also very limited.
SEBSs were placed endoscopically in 6 patients with
BBSs involving the distal common bile duct (2 secondary
to CP, 4 with undefined cause).4
A large retrospective multicenter study5 evaluated the
results of percutaneous placement of SEBSs in BBSs and
reported recurrence of 18% after less than 2 years of
follow-up. Furthermore, this series included patients withwww.giejournal.orgdifferent causes of BBSs, 63% of them having strictures
of a biliodigestive anastomosis, which are significantly
different from PCBSs.
We believe that the very good long-term results ob-
tained by the MPS protocol in PCBSs are also due to a pro-
gressive dilation of the fibrotic tissue, which is obtained by
the increasing number of stents placed at each session,
avoiding any abrupt stretching like that caused by balloon
bilioplasty, which is immediately apparently very effective
but will inevitably induce further scarring.
BBSs have various causes with different stricture features
(long and involving the intrapancreatic portion of the com-
mon bile duct in CP, short and tight like anastomotic biliary
strictures after liver transplantation, close to themain hepat-
ic confluence in the setting of PCBSs). Treating all BBSs with
the same strategy is likemixing “apples and oranges.6”While
awaiting more consistent data on other alternatives, we
believe that the MPS strategy is currently still the preferred
option to permanently dilate PCBSs.DISCLOSURE
Dr Costamagna is the recipient of research support
from Olympus and a member of the advisory committee
for Boston Scientific and Cook Endoscopy. The other
author disclosed no financial relationships relevant to
this publication.
Guido Costamagna, MD, FACG
Andrea Tringali, MD, PhD
Digestive Endoscopy Unit
Fondazione Policlinico Universitario A. Gemelli IRCCS
Centre for Endoscopic Research Therapeutics and Training
Università Cattolica del Sacro Cuore
Rome, ItalyREFERENCES
1. Mauri G. Endoscopic plastic stents: Still the preferred option of treat-
ment for benign biliary stenosis? Gastrointest Endosc 2019;90:998-9.
2. Costamagna G, Tringali A, Perri V, et al. Endotherapy of postcholecystec-
tomy biliary strictures with multiple plastic stents: long-term results in a
large cohort of patients. Gastrointest Endosc. Epub 2019 Jun 5.
3. Devière J, Nageshwar Reddy D, Püspök A, et al. Successful management
of benign biliary strictures with fully covered self-expanding metal
stents. Gastroenterology 2014;147:385-95.
4. Siiki A, Rinta-Kiikka I, Sand J, et al. A pilot study of endoscopically in-
serted biodegradable biliary stents in the treatment of benign biliary
strictures and cystic duct leaks. Gastrointest Endosc 2018;87:1132-7.
5. Mauri G, Michelozzi C, Melchiorre F, et al. Benign biliary strictures refrac-
tory to standard bilioplasty treated using polydoxanone biodegradable
biliary stents: retrospective multicentric data analysis on 107 patients.
Eur Radiol 2016;26:4057-63.
6. Cotton PB. Endoscopic management of bile duct stones; (apples and or-
anges). Gut 1984;25:587-97.
https://doi.org/10.1016/j.gie.2019.08.011Volume 90, No. 6 : 2019 GASTROINTESTINAL ENDOSCOPY 999
